June 2016
The MRFF will be used to drive medical innovation, and is a massive opportunity to boost research translation and accelerate the development of discoveries into clinical reality in Australia.
The Australian Medical Research Advisory Board held its first meeting at Parliament House on 4 May 2016. Under the Medical Research Future Fund Act 2015, the Advisory Board is tasked with determining the Australian Medical Research and Innovation Strategy and related Priorities. The Strategy is determined every five years and the Priorities every two years.
Members of the Advisory Board requested input from the community to shape the Strategy and identify the Priorities for the Medical Research Future Fund.
The BioMelbourne Network Industry:Academic Advisory Group lead a consultative process incorporating the views of other BioMelbourne Network Members and the Board resulting in a submission which can be read here.
Due to the strong engagement we’ve had from members, BioMelbourne Network CEO, Dr Krystal Evans, has offered to host a discussion in Melbourne as part of the next stage of the consultation process – to talk with the MRFF Advisory Board about the submission and the Strategy for the MRFF in an effort to fully leverage our strong innovation ecosystem and to drive health and economic benefits for Australia.
Thank you again to all these who contributed to this particular submission and also for the other conversations that continue to shape the BioMelbourne Network policy platform. We’ll be taking a much stronger advocacy position in the lead up to the 2018 State Govt election.
Some of our Members have also kindly shared their submissions:
